2015, Innovation and Pharmaceuticals

New Map Shows Global Labor Flows

The Horizons Tracker

SEPTEMBER 17, 2019

The data revealed some interesting patterns, including some unexpected connections between industries such as credit cards and air travel, while also being a fairly accurate barometer of the overall health of industries, with the likes of oil and gas and pharmaceuticals doing well, whereas retail and telecoms struggled.

Globalization

Globalization Pharmaceuticals Comparison Industry

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation

Innovation Short-term Telecommunications Long-term

Even Life-Saving Innovations Don’t Sell Themselves

Harvard Business Review

FEBRUARY 16, 2017

The same is true for social innovators. However, unlike many business leaders, it is easy for social innovators to overlook making an intentional effort to drive demand because the need for their innovation is so great. But even the most needed innovation does not sell itself. Consider that 86 million U.S.

Innovation

Innovation Rogers NGO Participative

Despite Dire Predictions, Salespeople Aren’t Going Away

Harvard Business Review

MARCH 31, 2016

Fast forward to 2015. Over the years, innovations in distribution, media, and technology have enabled buyers to use non-sales force channels for various steps of their buying journey. For example, between 1995 and 2013, the top five pharmaceutical companies shed more than 55% of their salespeople in the US.

B2B

B2B B2C Uncertainty Self-aware

Startups Are Turning Customers into Lobbyists

Harvard Business Review

OCTOBER 24, 2017

In early 2015 the government announced its intention to auction 450 beer licenses to grocery stores, citing Ontarian’s demands as the motivating factor. Uber learned this lesson the hard way in its bid to enter Calgary in October 2015 when its petition reached 14,000 signatures – only 1.2%

Licensing

Licensing Proposal Retail Long-term

Offices Can Be Bastions of Civility in an Uncivil Time

Harvard Business Review

JULY 14, 2017

A recent survey on easing racial tensions at work by the Center for Talent Innovation found that “The workplace is one of few settings where we commonly interact across racial and ethnic lines.” ” Prompted in 2015 by fatal police shootings in Ferguson, Missouri, and other cities, the company now holds “ Can We Talk ?

Diversity

Diversity Politics Survey Incubator

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO

CEO Innovation Pharmaceuticals Merchandising

How to Actually Put Your Marketing Data to Use

Harvard Business Review

OCTOBER 27, 2015

At UCB, a medium-sized pharmaceutical company headquartered in Belgium, Heresh Rezavandi and his managers Michelle Maddix-Sovero are leading a young strategic intelligence function that’s part of the strategic marketing practice. It also began innovating new services offerings to diversify its portfolio.

Marketing

Marketing Competitive Intelligence Porter How To

Navigating the Dozens of Different Strategy Options

Harvard Business Review

JUNE 24, 2015

In this adaptation from the new book, Your Strategy Needs a Strategy (HBR Press, 2015), BCG strategy experts make sense of the all the different, and competing, approaches to strategy: Which strategy is right for your business? When and how should you implement it? Firms deploying a visionary approach also follow a distinct thought flow.

Strategy

Strategy Competitive Advantage Environment Execution

Price Gouging and the Dangerous New Breed of Pharma Companies

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price

Price Pharmaceuticals Company Health Care

3 Health Care Trends That Don’t Hinge on the ACA

Harvard Business Review

MAY 25, 2017

From 2015 to 2016, investors poured more than $8 billion into funding these tools. How the most innovative providers are creating value. While new EHR offerings continue to emerge, the market has consolidated around a few large players, which has held back innovation and interoperability. Insight Center. Sponsored by Optum.

Health Care

Health Care Trends Venture Funding Technology

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business Review

APRIL 6, 2017

I help the University of Utah hospital system manage its drug budgets and medication use policies, and in 2015 I got sticker shock. The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. How generics are supposed to work. Not anymore.

System

System Pharmaceuticals Company Sample